Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-re...

Full description

Saved in:
Bibliographic Details
Main Authors: Patel, Nish, Chatterjee, Sabarni K., Vrbanac, Vladimir, Chung, Ivy, Mu, Chunyao Jenny, Olsen, Rachelle R., Waghorne, Carol, Zetter, Bruce R.
Format: Article
Published: National Academy of Sciences 2010
Subjects:
Online Access:http://eprints.um.edu.my/5085/
https://doi.org/10.1073/pnas.0910649107
Tags: Add Tag
No Tags, Be the first to tag this record!